Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. More Details
Imperfect balance sheet and overvalued.
Share Price & News
How has Paragon Care's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PGC has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: PGC underperformed the Australian Healthcare industry which returned 4% over the past year.
Return vs Market: PGC underperformed the Australian Market which returned -5.4% over the past year.
Price Volatility Vs. Market
How volatile is Paragon Care's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StShould You Use Paragon Care's (ASX:PGC) Statutory Earnings To Analyse It?
3 months ago | Simply Wall StParagon Care Limited (ASX:PGC) Might Not Be As Mispriced As It Looks
4 months ago | Simply Wall StWhat Is Paragon Care's (ASX:PGC) P/E Ratio After Its Share Price Tanked?
Is Paragon Care undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate PGC's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate PGC's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: PGC is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average.
PE vs Market: PGC is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PGC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PGC is good value based on its PB Ratio (0.6x) compared to the AU Healthcare industry average (1.4x).
How is Paragon Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Paragon Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of PGC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Paragon Care competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
How has Paragon Care performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PGC is currently unprofitable.
Growing Profit Margin: PGC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PGC is unprofitable, and losses have increased over the past 5 years at a rate of 30.9% per year.
Accelerating Growth: Unable to compare PGC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PGC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-6.1%).
Return on Equity
High ROE: PGC has a negative Return on Equity (-63.77%), as it is currently unprofitable.
How is Paragon Care's financial position?
Financial Position Analysis
Short Term Liabilities: PGC's short term assets (A$106.3M) exceed its short term liabilities (A$84.9M).
Long Term Liabilities: PGC's short term assets (A$106.3M) exceed its long term liabilities (A$95.0M).
Debt to Equity History and Analysis
Debt Level: PGC's debt to equity ratio (91.2%) is considered high.
Reducing Debt: PGC's debt to equity ratio has increased from 55.9% to 91.2% over the past 5 years.
Debt Coverage: PGC's debt is not well covered by operating cash flow (5.2%).
Interest Coverage: PGC is unprofitable, therefore interest payments are not well covered by earnings.
What is Paragon Care current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PGC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PGC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PGC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PGC's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: PGC is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PGC's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Phil Nicholl, BBus (CSU) serves as Chief Executive Officer at Paragon Care Limited since November 27, 2019 and served as its Head of Device Division. Mr. Nicholl is the Chief Executive Officer of one o ...
CEO Compensation Analysis
Compensation vs Market: Phil's total compensation ($USD313.81K) is about average for companies of similar size in the Australian market ($USD274.65K).
Compensation vs Earnings: Insufficient data to compare Phil's compensation with company performance.
|Chief Executive Officer||0.92yr||AU$440.88k||0.52% |
|Chief Financial Officer||0.83yr||AU$229.12k||no data|
|Company Secretary||no data||no data||no data|
|Group Commercial Manager||2.42yrs||AU$304.03k||no data|
Experienced Management: PGC's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
|Independent Non-Executive Chairman||10.42yrs||AU$111.00k||0.25% |
|Non-Executive Independent Director||4.33yrs||AU$83.24k||0.51% |
|Independent Non-Executive Director||2.42yrs||AU$55.50k||0.88% |
|Non-Executive Director||0.92yr||AU$30.50k||0.084% |
Experienced Board: PGC's board of directors are considered experienced (3.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Paragon Care Limited's company bio, employee growth, exchange listings and data sources
- Name: Paragon Care Limited
- Ticker: PGC
- Exchange: ASX
- Founded: 1994
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: AU$67.577m
- Shares outstanding: 337.89m
- Website: https://www.paragoncare.com.au
Number of Employees
- Paragon Care Limited
- 96-100 Albert Road
- Level 4
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PXS||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Oct 1999|
|PGC||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Oct 1999|
|PGC||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Oct 1999|
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/22 10:37|
|End of Day Share Price||2020/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.